Clinical Practice and Quality Control Strategies for Complex Minimally Invasive Pancreatic Surgery
- VernacularTitle:困难胰腺微创手术的临床实践与质量控制策略
- Author:
Jingwen LI
1
;
Zhong WU
;
Bing PENG
Author Information
- Keywords: Laparoscope; Minimally invasive; Pancreatic surgery; Laparoscopic pancreaticoduodenectomy; Review
- From: Journal of Sichuan University (Medical Sciences) 2025;56(4):997-1002
- CountryChina
- Language:Chinese
- Abstract: With continuous advancements in the concepts of minimally invasive surgery,pancreatic surgery is gradually undergoing a transformative shift toward minimally invasive approaches.Compared with traditional open surgeries,minimally invasive procedures offer advantages such as reduced trauma,faster recovery,and fewer complications.However,due to the complex anatomical structure of the pancreas and the technical difficulties of surgical procedures,the widespread adoption of minimally invasive pancreatic surgery still faces numerous technical challenges.Currently,laparoscopic pancreaticoduodenectomy(LPD)is primarily performed in large,specialized centers with experienced teams and well-established systems.Given the high technical complexity and associated risks,reducing intraoperative risks and minimizing postoperative complications remain key focuses and major challenges in current research.This review is focused on intraoperative risk control and postoperative complication management in complex minimally invasive pancreatic surgery.We conducted a comprehensive review of recent advances in China and abroad,covering the latest progress in preoperative assessment,intraoperative procedures,complication prevention,quality management,and technological innovation.Furthermore,we discussed potential development directions in minimally invasive pancreatic surgery,including technical refinement,discipline development,procedural standardization,and multi-center collaboration.Our goal is to promote a continued progress toward more standardized,personalized,and intelligent surgical practices—ultimately benefiting a broader population of patients with pancreatic diseases.
